Contract award · 1 Sep 2023

Ravulizumab IV Infusion

Belfast Health and Social Care Trust awarded “Ravulizumab IV Infusion” to Alexion Pharma UK Ltd for £320k on 1 Sep 2023. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsNorthern Ireland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
Belfast Health and Social Care Trust · Body governed by public law
Value
£320,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Medical equipments, pharmaceuticals and personal care products (CPV 33000000)
Timeline
  1. Contract date1 Sep 2023
  2. Published4 Sep 2023Published 3 days after the contract date

Description

Procurement of Ravulizumab IV Infusion

About the supplier

More from Belfast Health and Social Care Trust

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview